By Professor David Thomas

Journal articles

Thomas DM; Ferguson GD; Herschman HR; Elferink LA, 1999, 'Functional and biochemical analysis of the C2 domains of synaptotagmin IV.', Mol Biol Cell, 10, pp. 2285 - 2295, http://dx.doi.org/10.1091/mbc.10.7.2285

Ferguson GD; Thomas DM; Elferink LA; Herschman HR, 1999, 'Synthesis degradation, and subcellular localization of synaptotagmin IV, a neuronal immediate early gene product.', J Neurochem, 72, pp. 1821 - 1831, http://dx.doi.org/10.1046/j.1471-4159.1999.0721821.x

Kuhn DM; Arthur RE; Thomas DM; Elferink LA, 1999, 'Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease.', J Neurochem, 73, pp. 1309 - 1317, http://dx.doi.org/10.1046/j.1471-4159.1999.0731309.x

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Correction: Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer (Medical Journal of Australia (1998) 169 (227))', Medical Journal of Australia, 169, pp. 344

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer (vol 169, pg 227, 1998)', MEDICAL JOURNAL OF AUSTRALIA, 169, pp. 344 - 344, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076023200028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomas DM; Udagawa N; Hards DK; Quinn JMW; Moseley JM; Findlay DM; Best JD, 1998, 'Insulin receptor expression in primary and cultured osteoclast-like cells', Bone, 23, pp. 181 - 186, http://dx.doi.org/10.1016/S8756-3282(98)00095-7

Thomas DM; Elferink LA, 1998, 'Functional analysis of the C2A domain of synaptotagmin 1: implications for calcium-regulated secretion.', J Neurosci, 18, pp. 3511 - 3520, http://dx.doi.org/10.1523/JNEUROSCI.18-10-03511.1998

Thomas DM; Zalcberg JR, 1998, '5-Fluorouracil: A pharmacological paradigm in the use of cytotoxics', Clinical and Experimental Pharmacology and Physiology, 25, pp. 887 - 895, http://dx.doi.org/10.1111/j.1440-1681.1998.tb02339.x

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer [1]', Medical Journal of Australia, 169, pp. 227, http://dx.doi.org/10.5694/j.1326-5377.1998.tb140229.x

Thomas DM; Seymour JF; Szer J; Grigg AP; Basser RL; Green MD; Fox RM; Thomas DM, 1998, 'Progress in management of acute myeloid leukaemia (AML) in Australia since 1980: A single institution retrospective study', Australian and New Zealand Journal of Medicine, 28, pp. 190 - 196, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02968.x

Rosenblatt K; Thomas D, 1997, 'Association between tubal ligation and endometrial cancer.', Int J Cancer, 71, pp. 129 - 130, http://dx.doi.org/10.1002/(sici)1097-0215(19970328)71:1<129::aid-ijc22>3.0.co;2-c

Thomas DM; Ng KW; Best JD, 1997, 'Insulin and bone: A clinical and scientific review', Endocrinology and Metabolism Supplement, 4, pp. 5 - 17

Thomas DM; Seymour JF; Griffiths JD; Szer J; Grigg AP, 1997, 'Prolonged disease-free survival with specific re-induction therapy in acute myeloid leukaemia relapsing following bone marrow transplantation', Australian and New Zealand Journal of Medicine, 27, pp. 712 - 713, http://dx.doi.org/10.1111/j.1445-5994.1997.tb01009.x

Rosenblatt KA; Thomas DB; Berry G; MacLennan R; Shearman R; Jelihovsky T; Booth JC; Molina R; Martinez L; Salas O; Dabancens A; Zhiheng C; Yun T; Wei HY; Modan B; Ron E; Alfandary E; Rodriguez Cuevas H; Benavides Salazar S; Palet A; Ontiveros P; Apelo RA; De La Cruz JR; Baens J; Javier B; Silpisornkosol S; Pardthaisong T; Martin N; Theetranont C; Boosiri B; Chutivongse S; Virutamasen P; Wongsrichanalai C; Jimakorn P; Koetsawang S; Rachawat D; Chantarakul N; Langley FA; Noonan EA; Hoick S; Farley T; Meirik O, 1996, 'Intrauterine devices and endometrial cancer', Contraception, 54, pp. 329 - 332, http://dx.doi.org/10.1016/S0010-7824(96)00199-0

Thomas DM; Maher F; Rogers SD; Best JD, 1996, 'Expression and regulation by insulin of Glut 3 in UMR 106-01, a clonal rat osteosarcoma cell line', Biochemical and Biophysical Research Communications, 218, pp. 789 - 793, http://dx.doi.org/10.1006/bbrc.1996.0140

Thomas DM; Rogers SD; Ng KW; Best JD, 1996, 'Dexamethasone modulates insulin receptor expression and subcellular distribution of the glucose transporter GLUT 1 in UMR 106-01, a clonal osteogenic sarcoma cell line', Journal of Molecular Endocrinology, 17, pp. 7 - 17, http://dx.doi.org/10.1677/jme.0.0170007

Thomas DM; Hards DK; Rogers SD; Ng KW; Best JD, 1996, 'Insulin receptor expression in bone', Journal of Bone and Mineral Research, 11, pp. 1312 - 1320, http://dx.doi.org/10.1002/jbmr.5650110916

Thomas DM; Rogers SD; Sleeman MW; Pasquini GM; Bringhurst FR; Ng KW; Zajac JD; Best JD, 1995, 'Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line', Journal of Molecular Endocrinology, 14, pp. 263 - 275, http://dx.doi.org/10.1677/jme.0.0140263

Prentice RL; Thomas D, 1993, 'Methodologic research needs in environmental epidemiology: data analysis.', Environ Health Perspect, 101 Suppl 4, pp. 39 - 48, http://dx.doi.org/10.1289/ehp.93101s439

Lazovich D, 1992, 'Breast-Conserving Surgery and Radiation Therapy: Are They Underused?-Reply', JAMA: The Journal of the American Medical Association, 268, pp. 869 - 869, http://dx.doi.org/10.1001/jama.1992.03490070047024

Silpisornkosol S; Pardthaisong T; Sahapong V; Theetranont C; Boosiri B; Chutivongse S; Virutamasen P; Wongsrchanalai C; Sindhvananda S; Koetsawang S; Rachawat D; Koetsawang A; Langley FA; Thomas Study Coordinator DB; Ray RM; Noonan EA; Stanford JL; Rosenblatt KA; Holck S; Farley TMM; Thomas DB, 1991, 'Depot‐medroxyprogesterone acetate (dmpa) and risk of edometrial cancer', International Journal of Cancer, 49, pp. 186 - 190, http://dx.doi.org/10.1002/ijc.2910490207

Witherspoon RP; Fisher LD; Schoch G; Martin P; Sullivan KM; Sanders J; Deeg HJ; Doney K; Thomas D; Storb R, 1989, 'Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.', N Engl J Med, 321, pp. 784 - 789, http://dx.doi.org/10.1056/NEJM198909213211203

Severson RK; Stevens RG; Davis S; Thomas D; Heuser L; Sever LE, 1989, 'THE AUTHORS REPLY', American Journal of Epidemiology, 130, pp. 425 - 427, http://dx.doi.org/10.1093/oxfordjournals.aje.a115352

Conference Papers

Thomas DM; Daniele G; Kim JE; Gadgeel SM; Ahn ER; Paz-Ares LG; Prenen H; Chen D; Fang J; Wilson TR; Simmons BP; Barlesi F, 2024, 'Ipatasertib in patients with AKT1/2/3 mutation-positive (AKTmut) tumors: TAPISTRY study', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Special Clinical Science Symposia, ELECTR NETWORK, 29 May 2024 - 29 May 2024

Pavlakis N; Millward M; Richardson G; Andelkovic V; Kichenadasse G; Thomas DM; Fernandez AM; Thakkar D; Arbabzade T; Goey CH; Seet Q; Toy W; Paszkiewicz K; Ingram PJ; Boyd-Kirkup JD; Kwek KY, 2023, 'A phase Ib study of HMBD-001, a monoclonal antibody targeting HER3, with or without chemotherapy in patients with genetic aberrations in HER3 signaling', in ANNALS OF ONCOLOGY, ELSEVIER, SINGAPORE, pp. S1501 - S1501, presented at Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, 01 December 2023 - 03 December 2023, http://dx.doi.org/10.1016/j.annonc.2023.10.788

McNamee N; Lin F; Sim H-W; Napier C; Thomas D; Simes J; Thavaneswaran S, 2023, 'EXPLORING THE PROGNOSTIC IMPLICATIONS OF MOLECULAR ALTERATIONS IN ASTROCYTOMAS USING COMPREHENSIVE GENOMIC PROFILING (CGP)', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, CANADA, Vancouver, presented at 28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO), CANADA, Vancouver, 15 November 2023 - 19 November 2023

Zeverijn LJ; Looze E; Thavaneswaran S; Henegouwen JMVB; Simes J; Hoes LR; Geurts B; Sebastian L; Roepman P; Lin FP-Y; Jansen AML; de Leng WWJ; van der Noort V; Leek LVM; de Vos FYFL; Verheul HMW; Gelderblom H; Thomas DM; Voest EE; Sjoquist KM, 2023, 'Clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023

Zaheed M; Napier CE; Cops EJ; Ferris N; Moodie K; Milner B; Moses D; Poplawski N; Dow EG; Harris M; Tucker K; Trainer A; James P; Thomas DM; Ballinger ML, 2023, 'Long-term clinical and psychosocial outcomes of surveillance in Li Fraumeni syndrome.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023

Thomas DM, 2022, 'A population-based, whole genome sequencing approach to mapping the genetic basis of mesenchymal malignancies', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH

Scott CL; Lim R; Kee D; Georgiou C; Caldwell R; Papadopoulos L; Krasovitsky MS; Tay R; Bourne A; Vandenberg C; Dall G; Shield-Artin K; Carmagnac A; Ratnayak G; Tram J; Zhou W; Bedo J; Penington J; Zhu L; Vissers J; Thomas D; Grimmond S; Wakefield M; Papenfuss T; Barke H; Goldstein D, 2021, 'Delivering personalized care and research for rare cancers in the increasingly genomic world?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500102&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P, 2021, 'Effectively communicating comprehensive tumour genomic profiling results: Mitigating uncertainty for advanced cancer patients', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 180 - 180, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500295&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomas D, 2021, 'MOST study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 91 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500101&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vatter S; Schlub TE; Napier CE; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker BB; Goldstein D; Thomas DM; Butow P, 2021, 'Psychological outcomes in advanced cancer patients after receiving genomic tumour profiling results', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 198 - 198, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500332&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomas DM, 2021, 'MTOR signaling orchestrates stress-induced mutagenesis facilitating adaptive evolution in human cancers', in CANCER SCIENCE, WILEY, pp. 182 - 182, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000618060100103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kee D; Kondrashova O; Hadley A; Brown MP; Dean A; Rico GT; Cohen P; Mileshkin L; Ananda S; O'Byrne K; Lindsay D; Vines R; Fox S; Desai J; Thomas D; Waddell N; Fellowes A; Papenfuss T; Scott CL, 2020, 'Outcomes in rare cancer patients who underwent comprehensive genomic sequencing in the NOMINATOR study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 70 - 70, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000790145400028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kee D; Kondrashova O; Ananda S; Brown MP; Cohen PA; Dean A; Desai J; Fellowes A; Fox SB; Hadley A; Lindsay D; Mileshkin LR; O'Byrne KJ; Prall OWJ; Scott H; Thomas DM; Vines R; Waddell N; Papenfuss A; Scott CL, 2020, 'NOMINATOR: Feasibility of genomic testing of rare cancers to match cancer to treatment.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368300004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Butow P; Best M; Davies G; Schlub T; Napier C; Bartley N; Ballinger M; Juraskova I; Meiser B; Goldstein D; Biesecker B; Thomas D, 2020, 'Psychological impact of comprehensive genomic profiling results to advanced cancer patients', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 92 - 92

Best M; Butow P; Jacobs C; Savard J; Biesecker B; Ballinger M; Bartley N; Davies G; Napier CE; Smit AE; Thomas D; Newson AJ, 2019, 'Who should access germline genome sequencing? A mixed methods study of patient views', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 92 - 93, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shin SJ; Dodd E; Peng G; Bojadzieva J; Chen J; Ning J; Mai PL; Savage SA; Ballinger ML; Thomas DM; Yuan Y; Strong LC; Wang W, 2019, 'Abstract 2434: Characterizing age-of-onset of multiple primary cancers and specific cancer types in families with Li-Fraumeni syndrome', in Prevention, Early Detection, and Interception, American Association for Cancer Research, pp. 2434 - 2434, presented at Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA, http://dx.doi.org/10.1158/1538-7445.sabcs18-2434

Shin SJ; Dodd E; Peng G; Bojadzieva J; Chen J; Ning J; Mai PL; Savage SA; Ballinger ML; Thomas DM; Yuan Y; Strong LC; Wang W, 2019, 'Characterizing age-of-onset of multiple primary cancers and specific cancer types in families with Li-Fraumeni syndrome', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), GA, Atlanta, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-2434

Ballinger ML; Pinese M; Thomas DM, 2019, 'Translating genomic risk into an early detection strategy for sarcoma', in Genes Chromosomes and Cancer, pp. 130 - 136, http://dx.doi.org/10.1002/gcc.22697

Best M; Bartley N; Jacobs C; Juraskova I; Newson A; Savard J; Meiser B; Ballinger M; Thomas D; Biesecker B; Butow P, 2018, 'Advanced cancer patient perspectives on consenting to molecular tumour profiling: A qualitative study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 144 - 144, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200232&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Best M; Bartley N; Jacobs C; Juraskova I; Newson A; Savard J; Meiser B; Ballinger M; Thomas D; Biesecker B; Butow P, 2018, 'Young cancer patient perspectives on undertaking whole genome sequencing: A qualitative study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 144 - 144, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200231&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Barnet MB; Jackson KJ; Gao B; Nagrial AM; Boyer MJ; Cooper WA; Hui R; Linton A; Tattersall MH; Gibson G; Cebon J; Long GV; Menzies AM; Scolyer RA; Lacaze P; Brink R; Peters T; Cowley M; Gayevskiy V; Thomas DM; Pinese M; Blinman P; Kao S; Goodnow CC, 2018, 'Exploring the germ-line contribution to exceptional response to PD-1/PD-L1 inhibition in patients with metastatic non-small-cell lung cancer by whole genome sequencing', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, IL, Chicago, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), IL, Chicago, 14 April 2018 - 18 April 2018, http://dx.doi.org/10.1158/1538-7445.AM2018-LB-121

Koster R; Panagiotou OA; Wheeler WA; Karlins E; Gastier-Foster JM; Caminada de Toledo SR; Petrilli AS; Flanagan AM; Tirabosco R; Andrulis IL; Wunder JS; Gokgoz N; Patino-Garcia A; Lecanda F; Serra M; Hattinger C; Picci P; Scotlandi K; Thomas DM; Ballinger ML; Gorlick R; Barkauskas DA; Spector LG; Tucker M; Hicks B; Yeager M; Hoover R; Chanock SJ; Savage SA; Mirabello LJ, 2018, 'Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, IL, Chicago, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), IL, Chicago, 14 April 2018 - 18 April 2018, http://dx.doi.org/10.1158/1538-7445.AM2018-2077

Cain JE; Cochrane CR; Vaghjiani V; Szczepny A; Mccaw A; Carey K; Martelotto L; Kansara M; Thomas D; Walkley C; Matsui WH; Watkins DN, 2018, 'p53 and RB regulate Hedgehog responsiveness via autophagy-mediated ciliogenesis', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, IL, Chicago, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), IL, Chicago, 14 April 2018 - 18 April 2018, http://dx.doi.org/10.1158/1538-7445.AM2018-4994

Dancsok AR; Thomas D; Blay J-Y; Maki RG; Nielsen TO; Demicco EG, 2018, 'Abstract B32: Lymphocytes and immune checkpoint biomarker expression in sarcomas', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. B32 - B32, http://dx.doi.org/10.1158/1557-3265.sarcomas17-b32

Pinese M; Ballinger M; Thomas D, 2018, 'Abstract IA03: Translating genomic risk into an early detection strategy for sarcoma', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. IA03 - IA03, http://dx.doi.org/10.1158/1557-3265.sarcomas17-ia03

Kansara M; Pang P; Sulkowski N; Teng M; Smyth M; Thomas D, 2018, 'Abstract PR13: Pivotal role of interleukin 23 in osteosarcoma development and its link with glutamate metabotropic 4: Identification of novel therapeutic targets for osteosarcoma', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. PR13 - PR13, http://dx.doi.org/10.1158/1557-3265.sarcomas17-pr13

Ishaque S; Roberts R; Karnon J; Thomas D; Salter A, 2018, 'Adaptation/ content validation of measure yourself medical outcomes profile (MYMOP) questionnaire for 7-11 year old children', in QUALITY OF LIFE RESEARCH, SPRINGER, pp. S114 - S115

Back to profile page